Short answer
Tirzepatide is a synthetic peptide that activates two incretin receptors - GIP and GLP-1 - in a single molecule. It is studied in metabolic pathway research as an example of a dual receptor agonist. PEPMAKE sells it as a lyophilized research powder for laboratory use only.
What is tirzepatide?
Tirzepatide is a dual GIP/GLP-1 receptor agonist. GIP (glucose-dependent insulinotropic polypeptide) and GLP-1 (glucagon-like peptide-1) are both natural incretin hormones, and tirzepatide was engineered to combine activity at both receptors in one peptide [1].
Because it engages two receptor systems, tirzepatide is a common tool in research questions about:
Research background
Incretin-based peptides are a major focus of metabolic research, and dual agonists represent a newer generation of tools [1][2]. The SURMOUNT clinical trial program, published in the New England Journal of Medicine, is frequently referenced in the metabolic literature as background on tirzepatide [2].
Key facts at a glance
| Property | Detail |
|---|---|
| Type | Dual GIP/GLP-1 receptor agonist |
| Receptor targets | GIP receptor + GLP-1 receptor |
| Research themes | Incretin signaling, metabolic pathways |
| Typical form | Lyophilized powder |
| Purity expectation | 99%+ by HPLC |
Buying checklist
Browse Tirzepatide product options or the GLP-1 research category.
FAQ
What is tirzepatide?
A dual GIP/GLP-1 receptor agonist peptide.
What does dual agonist mean?
One molecule activates two receptors - GIP and GLP-1.
How is it studied?
Receptor pharmacology, cell signaling and metabolic research models.
Is it for human use?
No, laboratory research use only.